Terri Clevenger is a Managing Director in ICR’s Healthcare PR Practice. With more than 30 years of healthcare communications expertise, Terri founded Continuum Health Communications in 2006, which became part of ICR in 2018.
A seasoned corporate communications counselor and product marketing expert, Terri helps clients better achieve their business goals through thoughtful and strategic communications programs that achieve measurable impact with targeted audiences.
A primary interest for Terri remains advocacy relations. She attributes it to the “thrill and satisfaction” of building strong working relationships between patient organizations and industry to create innovative and award-winning campaigns that make a difference in the lives of patients.
Terri’s strategic thinking and creative programming have impacted patients in a variety of disease areas, including oncology, neurology, respiratory, autoimmune diseases, ophthalmology, cardiology, hematology, endocrinology, children’s health, women’s health, and pulmonology. In addition, she has worked in the personalized medicine arena including molecular diagnostics, Cdx, electrical medicine and genomic sequencing. Terri has helped companies prepare and educate stakeholders during health crises, such as working with McKesson in preparation of delivering the H1N1 vaccine in concert with its partnership with Centers for Disease Control and Prevention (CDC) during the H1N1 Flu outbreak in 2009.
In 2012 Terri was named to the PharmaVoice 100 most influential in the industry. And in 2016 she was named a “Woman of Distinction” by WMD Magazine and was inducted into the 2016-2017“VIP Woman of the Year Circle” by the National Association of Professional Women. She has lectured in numerous industry and academic settings about the need for a strong link between patients and drug, diagnostic, and device development, including as a guest lecturer at the Kellogg School of Management at Northwestern University and the Wharton Undergraduate Healthcare Club. She is a recent graduate of the Goldman Sachs 10,000 Small Businesses program and the Inner City Capital Connections program.
Read Terri’s post: Progress in Patient Advocacy Relations: Great Partners in Challenging Times